{"transactions":[{"id":780316,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":47581,"kind":"person","name":"Vairavan Latha","position":1,"cik":"0002065881","reported_name":"Vairavan Latha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-13T23:43:28.000Z","date":"2026-05-11","kind":"sale","planned":true,"acquired":false,"shares":435,"price":21.05,"value":9156.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."}],"balance_after":85978,"source":{"system":"sec-edgar","filing":"0002065881-26-000004","document":"wk-form4_1778715805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000206588126000004/wk-form4_1778715805.xml","form_type":"4"}},{"id":789423,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":47581,"kind":"person","name":"Vairavan Latha","position":1,"cik":"0002065881","reported_name":"Vairavan Latha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-06T22:13:15.000Z","date":"2026-05-04","kind":"sale","planned":true,"acquired":false,"shares":1341,"price":23.6106,"value":31661.8146,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $23.16 to $23.93, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":86413,"source":{"system":"sec-edgar","filing":"0002065881-26-000002","document":"wk-form4_1778105592.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000206588126000002/wk-form4_1778105592.xml","form_type":"4"}},{"id":864735,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":47581,"kind":"person","name":"Vairavan Latha","position":1,"cik":"0002065881","reported_name":"Vairavan Latha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-04T01:42:09.000Z","date":"2026-02-27","kind":"grant","planned":true,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from March 1, 2026 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":70000,"derivative":{"exercise_price":26.97,"expiration_date":"2036-02-27","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001628280-26-014325","document":"wk-form4_1772588527.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026014325/wk-form4_1772588527.xml","form_type":"4"}},{"id":864734,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":47581,"kind":"person","name":"Vairavan Latha","position":1,"cik":"0002065881","reported_name":"Vairavan Latha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-04T01:42:09.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":81,"price":25.914,"value":2099.034,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.70 to $26.10, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":87754,"source":{"system":"sec-edgar","filing":"0001628280-26-014325","document":"wk-form4_1772588527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026014325/wk-form4_1772588527.xml","form_type":"4"}},{"id":864733,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":47581,"kind":"person","name":"Vairavan Latha","position":1,"cik":"0002065881","reported_name":"Vairavan Latha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-04T01:42:09.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":2772,"price":25.1605,"value":69744.906,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.69 to $25.67, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":87835,"source":{"system":"sec-edgar","filing":"0001628280-26-014325","document":"wk-form4_1772588527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026014325/wk-form4_1772588527.xml","form_type":"4"}},{"id":864732,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":47581,"kind":"person","name":"Vairavan Latha","position":1,"cik":"0002065881","reported_name":"Vairavan Latha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-04T01:42:09.000Z","date":"2026-02-27","kind":"grant","planned":true,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Constitute Restricted Stock Units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting, in which 25% of the RSUs vest annually on March 1, (the \"Vesting Commencement Date\"), of each year beginning March 1, 2027, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":90607,"source":{"system":"sec-edgar","filing":"0001628280-26-014325","document":"wk-form4_1772588527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026014325/wk-form4_1772588527.xml","form_type":"4"}},{"id":918863,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":47581,"kind":"person","name":"Vairavan Latha","position":1,"cik":"0002065881","reported_name":"Vairavan Latha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-05T00:24:25.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":1320,"price":25.4984,"value":33657.888,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligation in connection with the vesting of Restricted Stock Units (\"RSUs\"), granted on January 12, 2024, in which 25% of the RSUs vest annually on February 1, (the \"Vesting Commencement Date\"), of each year beginning on February 1, 2025, subject to the Reporting Person's continued service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.745 to $25.68, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":63607,"source":{"system":"sec-edgar","filing":"0001628280-26-005568","document":"wk-form4_1770251062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026005568/wk-form4_1770251062.xml","form_type":"4"}},{"id":1006528,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":47581,"kind":"person","name":"Vairavan Latha","position":1,"cik":"0002065881","reported_name":"Vairavan Latha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-05T23:24:05.000Z","date":"2025-11-03","kind":"sale","planned":true,"acquired":false,"shares":88,"price":24.7185,"value":2175.228,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.435 to $25.31, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":64927,"source":{"system":"sec-edgar","filing":"0002065881-25-000035","document":"wk-form4_1762385042.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000206588125000035/wk-form4_1762385042.xml","form_type":"4"}},{"id":1073853,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":47581,"kind":"person","name":"Vairavan Latha","position":1,"cik":"0002065881","reported_name":"Vairavan Latha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-05T22:28:52.000Z","date":"2025-08-04","kind":"sale","planned":true,"acquired":false,"shares":89,"price":14.3266,"value":1275.0674,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.98 to $14.67, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":65015,"source":{"system":"sec-edgar","filing":"0001787306-25-000117","document":"wk-form4_1754432928.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730625000117/wk-form4_1754432928.xml","form_type":"4"}},{"id":1155859,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":47581,"kind":"person","name":"Vairavan Latha","position":1,"cik":"0002065881","reported_name":"Vairavan Latha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-07T23:29:54.000Z","date":"2025-05-06","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest and become exercisable as to 1/48th of the shares on each monthly anniversary of   May 6, 2025 (the \"Vesting Commencement Date\"), subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":60000,"derivative":{"exercise_price":14.32,"expiration_date":"2035-05-06","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0002065881-25-000005","document":"wk-form4_1746660587.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000206588125000005/wk-form4_1746660587.xml","form_type":"4"}},{"id":1155858,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":47581,"kind":"person","name":"Vairavan Latha","position":1,"cik":"0002065881","reported_name":"Vairavan Latha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-07T23:29:54.000Z","date":"2025-05-06","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest as to 25% of the RSUs on each annual anniversary of May 1, 2025 (the \"Vesting Commencement Date\"), beginning on May 1, 2026, subject to the Reporting Person's continued service through the vesting date."}],"balance_after":65104,"source":{"system":"sec-edgar","filing":"0002065881-25-000005","document":"wk-form4_1746660587.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000206588125000005/wk-form4_1746660587.xml","form_type":"4"}}]}